Search results for: 'engineering research and development'
- Did you mean
- engineering research ad development
- Related search terms
- engineering Services Market automotive
- Research Radar in the Global Stationary Fuel Cell Market®ions=236
- development startup and future trend of ophthalmic drugs market
- development states and future trend of ophthalmic drugs market
- development startup ad future trend of ophthalmic drugs market
-
13 Dec 2021  |  Global  |  Technology Research
Technology Enablers Facilitating Microbiome Adoption in Research and Development
Advancements in Analytical Methods and Digital Tools Fuel Growth Opportunities in Microbiome Research and Product Development
Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Oct 2025  |  Global  |  Technology Research
Recent Advances in Biologics and AI-based Drug Discovery and Development
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...
$950.00 -
05 Aug 2024  |  Global  |  Technology Research
CGT Research Outlook and Technology Growth Opportunities
CGT Landscape Assessment
The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...
$4,950.00
Special Price $4,207.50 save 15 %
-
29 Jun 2023  |  Global  |  Technology Research
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
Disruptive Technology Advances in SynBio Foster a Thriving Stakeholder Ecosystem and Accelerate Biopharma Developments
The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 Sep 2025  |  Global  |  Technology Research
Technological Advances in Engineered Cell Therapies, Global, 2025–2029
Emerging Trends and Technologies in Engineered Cell Therapies
Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...
$4,950.00 -
23 Jun 2023  |  Global  |  Market Research
Global Tissue-engineered Skin Substitute Growth Opportunities
Breakthrough Technologies and Competitive Intensity Drive Innovation
Rising incidents of burn injuries, road accidents, and other trauma injuries, along with increasing cases of chronic wounds, such as diabetic ulcers and venous ulcers, are boosting the global tissue-engineered skin substitutes (TESS) market. Moreover, the increasing number of surgical injuries, plastic surgeries, cosmetic surgeries, and other recon...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Aug 2025  |  Global  |  Market Research
Cell Biology Research Market, Global, 2024–2030
Cell Biology Research is Experiencing Transformational Growth due to Advances in Single-Cell Technologies and Genomics Tools
In the study, Frost & Sullivan examines the global cell biology research market. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones. This growth reflects accelerating innovation across instrumentation, consumables, and software platforms, with a firm push from data-driven research models, ...
$4,950.00 -
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jul 2026  |  Global  |  Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
Expansion in Sterile Fill-Finish and ADC-Payload-Linkers Capabilities Will Meet Critical Demand for High-Value Injectables
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...
$2,450.00